The traditional funding path for companies and universities engaged in technology development has been via Federal Agencies (NIH, BARDA, HHS), Private Foundations, Corporate Licensing and the Venture Capital community. As funding via these channels is increasingly challenging, companies and universities will have to pivot and embrace alternative approaches to financing their activities.

In this meeting, a panel of experts will cover the following topics.

• The current funding climate
• VC funding
• Government sources
• Private foundations
• Specific examples of alternative approaches that Corporates/Universities have utilized to unlock value from their assets, notably
• IP portfolio sales
• Pharmaceutical Royalty Transactions
• Patent Licensing